Nighttime melatonin signaling refers to the crucial process by which the pineal gland releases the hormone melatonin in a darkness-dependent, circadian-controlled manner, and how this hormone then acts on its receptors (MT1 and MT2) throughout the body. This signal is the primary endocrine messenger of darkness, governing the synchronization of the sleep-wake cycle and regulating numerous physiological processes that occur during rest. Intact signaling is essential for sleep quality, immune function, and antioxidant defense.
Origin
This term is rooted in neuroendocrinology and chronobiology, describing the hormone’s function (“melatonin signaling”) during its peak release period (“nighttime”). Melatonin itself is derived from the Greek melas (black) and tonos (tone or tension). The discovery of its light-suppression mechanism established its role as the darkness hormone.
Mechanism
Darkness stimulates the suprachiasmatic nucleus (SCN) to signal the pineal gland, initiating the enzymatic conversion of serotonin to melatonin, which is then released into the circulation. Melatonin binds to its receptors in the SCN to reinforce the central clock’s timing and acts peripherally to lower body temperature and decrease alertness, facilitating sleep onset and maintenance. Disruption by light exposure at night suppresses this essential signal, leading to circadian misalignment. The MT1 and MT2 receptors mediate the chronobiotic effects.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.